Healthcare · Biotechnology · NASDAQ
| Market cap | $5.71B |
|---|---|
| Trailing P/E | — |
| FCF yield | -7.0% |
| Revenue growth (YoY) | -100.0% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
CRISPR Therapeutics AG trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| James M Inhofe | Senate | Sell | $15,001 - $50,000 | — |
| James M Inhofe | Senate | Buy | $15,001 - $50,000 | — |